Corteva, Inc. CTVA
We take great care to ensure that the data presented and summarized in this overview for Corteva, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CTVA
View all-
Vanguard Group Inc Valley Forge, PA78.5MShares$4.47 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY53.7MShares$3.05 Billion0.07% of portfolio
-
State Street Corp Boston, MA34.3MShares$1.95 Billion0.08% of portfolio
-
Capital International Investors Los Angeles, CA24.8MShares$1.41 Billion0.29% of portfolio
-
Aristotle Capital Management, LLC Los Angeles, CA23.7MShares$1.35 Billion2.7% of portfolio
-
Geode Capital Management, LLC Boston, MA17.7MShares$1.01 Billion0.09% of portfolio
-
Franklin Resources Inc San Mateo, CA14.8MShares$842 Million0.26% of portfolio
-
Harris Associates L P Chicago, IL14.4MShares$818 Million1.1% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL14.1MShares$803 Million0.24% of portfolio
-
Massachusetts Financial Services CO Boston, MA13MShares$741 Million0.24% of portfolio
Latest Institutional Activity in CTVA
Top Purchases
Top Sells
About CTVA
Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.
Insider Transactions at CTVA
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 26
2024
|
Cornel B Fuerer SVP, Gen Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
37,672
-22.88%
|
$2,373,336
$63.4 P/Share
|
Nov 26
2024
|
Cornel B Fuerer SVP, Gen Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
37,672
+18.62%
|
$1,695,240
$45.15 P/Share
|
Oct 31
2024
|
Nayaki R Nayyar |
BUY
Grant, award, or other acquisition
|
Direct |
533
+1.9%
|
$31,980
$60.92 P/Share
|
Oct 31
2024
|
Janet Plaut Giesselman |
BUY
Grant, award, or other acquisition
|
Direct |
114
+0.8%
|
$6,840
$60.92 P/Share
|
Sep 16
2024
|
David Paul Johnson EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
57,581
+50.0%
|
-
|
Jul 31
2024
|
Janet Plaut Giesselman |
BUY
Grant, award, or other acquisition
|
Direct |
124
+0.88%
|
$6,944
$56.1 P/Share
|
Jul 31
2024
|
Nayaki R Nayyar |
BUY
Grant, award, or other acquisition
|
Direct |
579
+2.1%
|
$32,424
$56.1 P/Share
|
May 14
2024
|
Cornel B Fuerer SVP, Gen Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
39,736
-23.89%
|
$2,264,952
$57.41 P/Share
|
May 14
2024
|
Cornel B Fuerer SVP, Gen Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
39,736
+19.28%
|
$1,231,816
$31.22 P/Share
|
May 09
2024
|
Samuel R Eathington |
SELL
Open market or private sale
|
Direct |
31,686
-37.04%
|
$1,806,102
$57.64 P/Share
|
May 09
2024
|
Samuel R Eathington |
BUY
Exercise of conversion of derivative security
|
Direct |
31,686
+27.04%
|
$1,045,638
$33.48 P/Share
|
May 06
2024
|
Brian Titus |
SELL
Open market or private sale
|
Direct |
12,134
-25.45%
|
$679,504
$56.73 P/Share
|
May 06
2024
|
Brian Titus |
BUY
Exercise of conversion of derivative security
|
Direct |
2,134
+7.69%
|
$87,494
$41.94 P/Share
|
Apr 30
2024
|
Janet Plaut Giesselman |
BUY
Grant, award, or other acquisition
|
Direct |
120
+0.86%
|
$6,480
$54.13 P/Share
|
Apr 30
2024
|
Nayaki R Nayyar |
BUY
Grant, award, or other acquisition
|
Direct |
600
+2.23%
|
$32,400
$54.13 P/Share
|
Apr 26
2024
|
Nayaki R Nayyar |
BUY
Grant, award, or other acquisition
|
Direct |
3,100
+10.76%
|
-
|
Apr 26
2024
|
Gregory R Page |
BUY
Grant, award, or other acquisition
|
Direct |
5,290
+8.21%
|
-
|
Apr 26
2024
|
Kerry J Preete |
BUY
Grant, award, or other acquisition
|
Direct |
3,100
+19.47%
|
-
|
Apr 26
2024
|
Pat Ward |
BUY
Grant, award, or other acquisition
|
Direct |
3,100
+8.73%
|
-
|
Apr 26
2024
|
Klaus A Engel |
BUY
Grant, award, or other acquisition
|
Direct |
3,100
+7.87%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 299K shares |
---|---|
Exercise of conversion of derivative security | 111K shares |
Payment of exercise price or tax liability | 80.3K shares |
---|---|
Open market or private sale | 121K shares |